News
Stay on top of industry trends and learn how Calyx is helping sponsors and CROs design and implement clinical trials effectively—and efficiently.
![](https://www.calyx.ai/wp-content/uploads/2023/06/CalyxUnblindingPartThree-600x300.png)
![](https://www.calyx.ai/wp-content/uploads/2023/07/2024-CalyxIRT-3-Ways-Evaluate-IRT-RTSM-Vendor-BlogHeader-600x300.jpg)
3 Study Areas Where Your IRT Vendor Should Do More
![](https://www.calyx.ai/wp-content/uploads/2024/06/SPECTCT_resized-PR-Invicro-600x300.jpg)
Calyx / Invicro Forges a Strategic Collaboration with BAMF Health to Accelerate Clinical Translation of Radioligand Therapies and Immuno-Oncology Agents
![](https://www.calyx.ai/wp-content/uploads/2024/06/Improving-Neuro-Psychiatric-Trial-Blog-Header-600x300.jpg)
Improving Neuro-Psychiatric Trial Outcomes through fMRI: An Interview with Emily Stern, MD, CEO and Co-founder, Ceretype Neuromedicine
![](https://www.calyx.ai/wp-content/uploads/2024/05/IRT-Design-Say-No-600x300.jpg)
Should your IRT / RTSM provider say “no” to design requests?
![](https://www.calyx.ai/wp-content/uploads/2023/12/25AUG2023-Webinar-AI-Imaging-Webinar-MK-Final-600x300.jpg)